Morgens Waterfall Vintiadis & CO Inc Adma Biologics, Inc. Transaction History

Morgens Waterfall Vintiadis & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.5 - $4.59 $900,000 - $2.75 Million	-600,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $194,500 - $257,500	50,000 Added 9.09%	600,000 $2.4 Million
Q2 2019 Aug 14, 2019	SELL	$3.52 - $5.24 $88,000 - $131,000	-25,000 Reduced 4.35%	550,000 $2.13 Million
Q1 2019 May 15, 2019	BUY	$2.61 - $4.35 $456,750 - $761,249	175,000 Added 43.75%	575,000 $2.18 Million
Q4 2018 Feb 14, 2019	BUY	$2.17 - $6.12 $54,250 - $153,000	25,000 Added 6.67%	400,000 $956,000
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $329,250 - $408,000	75,000 Added 25.0%	375,000 $1.69 Million
Q1 2018 May 15, 2018	SELL	$3.21 - $5.21 $642,000 - $1.04 Million	-200,000 Reduced 40.0%	300,000 $1.38 Million
Q4 2017 Feb 14, 2018	BUY	$2.06 - $3.24 $1.03 Million - $1.62 Million	500,000	500,000 $1.61 Million

320

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.48B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.